Browsing by Author Hao, Chuanming
Showing results 1 to 5 of 5
| Issue Date |
Title |
Author(s) |
| 2007 |
Antihypertensive effects of selective prostaglandin E-2 receptor subtype 1 targeting |
Guan, Youfei;Zhang, Yahua;Wu, Jing;Qi, Zhonghua;Yang, Guangrui;Dou, Dou;Gao, Yuansheng;Chen, Lihong;Zhang, Xiaoyan;Davis, Linda S.;Wei, Mingfeng;Fan, Xuefeng;Carmosino, Monica;Hao, Chuanming;Imig, John D.;Breyer, Richard M.;Breyer, Matthew D. |
| 2017 |
Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China |
Chen, Nan;Qian, Jiaqi;Chen, Jianghua;Yu, Xueqing;Mei, Changlin;Hao, Chuanming;Jiang, Gengru;Lin, Hongli;Zhang, Xinzhou;Zuo, Li;He, Qiang;Fu, Ping;Li, Xuemei;Ni, Dalvin;Hemmerich, Stefan;Liu, Cameron;Szczech, Lynda;Besarab, Anatole;Neff, Thomas B.;Yu, Kin-Hung Peony;Valone, Frank H. |
| 2016 |
Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B Study |
Zhou, Xianghai;Ji, Linong;Ran, Xingwu;Su, Benli;Ji, Qiuhe;Pan, Changyu;Weng, Jianping;Ma, Changsheng;Hao, Chuanming;Zhang, Danyi;Hu, Dayi |
| 2013 |
Primacy of the 3B Approach to Control Risk Factors for Cardiovascular Disease in Type 2 Diabetes Patients |
Ji, Linong;Hu, Dayi;Pan, Changyu;Weng, Jianping;Huo, Yong;Ma, Changsheng;Mu, Yiming;Hao, Chuanming;Ji, Qiuhe;Ran, Xingwu;Su, Benli;Zhuo, Hanjing;Fox, Keith A. A.;Weber, Michael;Zhang, Danyi |
| 2016 |
Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study |
Huo, Xiaoxu;Gao, Leili;Guo, Lixin;Xu, Wen;Wang, Wenbo;Zhi, Xinyue;Li, Ling;Ren, Yanfeng;Qi, Xiuying;Sun, Zhong;Li, Weidong;Ji, Qiuhe;Ran, Xingwu;Su, Benli;Hao, Chuanming;Lu, Juming;Guo, Xiaohui;Zhuo, Hanjing;Zhang, Danyi;Pan, Changyu;Weng, Jianping;Hu, Dayi;Yang, Xilin;Ji, Linong |
